Published in J Rheumatol on February 01, 1991
Compromised production of extracellular matrix in mice lacking secreted protein, acidic and rich in cysteine (SPARC) leads to a reduced foreign body reaction to implanted biomaterials. Am J Pathol (2003) 1.04
Increased SPARC expression in primary angle closure glaucoma iris. Mol Vis (2008) 0.96
Attenuation of fibrosis in vitro and in vivo with SPARC siRNA. Arthritis Res Ther (2010) 0.95
The Function of SPARC as a Mediator of Fibrosis. Open Rheumatol J (2012) 0.89
In silico whole-genome screening for cancer-related single-nucleotide polymorphisms located in human mRNA untranslated regions. BMC Genomics (2007) 0.79
Expression of SPARC (secreted protein, acidic and rich in cysteine) in healing intestinal anastomoses and short bowel syndrome in rats. Dig Dis Sci (1999) 0.78
Stimulated expression of decorin and the decorin gene in fibroblasts cultured from patients with localized scleroderma. Arch Dermatol Res (1995) 0.76
Protective role for miR-9-5p in the fibrogenic transformation of human dermal fibroblasts. Fibrogenesis Tissue Repair (2016) 0.75
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol (1988) 16.45
Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J (1999) 4.85
Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol (2000) 3.58
Survival with first-line bosentan in patients with primary pulmonary hypertension. Eur Respir J (2005) 2.83
Reliability of skin involvement measures in scleroderma. The UK Scleroderma Study Group. Br J Rheumatol (1992) 2.58
Population health and health care use: an information system for policy makers. Milbank Q (1996) 2.54
Predisposition to familial osteoarthrosis linked to type II collagen gene. Lancet (1989) 2.43
Localization of types I, II, and III collagen mRNAs in developing human skeletal tissues by in situ hybridization. J Cell Biol (1987) 2.41
Career differences between primary care and traditional trainees in internal medicine and pediatrics. Ann Intern Med (1992) 2.28
Characterization of primary cultures of chondrocytes from type II collagen/beta-galactosidase transgenic mice. Matrix Biol (1994) 2.12
Matrix metalloproteinases in wound repair (review). Int J Mol Med (2000) 1.98
Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res (1998) 1.83
Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet (1997) 1.76
A standardized experimental fracture in the mouse tibia. J Orthop Res (1993) 1.75
Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. Biochim Biophys Acta (1991) 1.67
Mouse type II collagen gene. Complete nucleotide sequence, exon structure, and alternative splicing. J Biol Chem (1991) 1.67
Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci (2000) 1.66
Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol (1997) 1.66
Integrin alpha2beta1 mediates isoform-specific activation of p38 and upregulation of collagen gene transcription by a mechanism involving the alpha2 cytoplasmic tail. J Cell Biol (1999) 1.65
Variation in indications for cataract surgery in the United States, Denmark, Canada, and Spain: results from the International Cataract Surgery Outcomes Study. Br J Ophthalmol (1998) 1.64
A randomised controlled trial of a community intervention to prevent adolescent tobacco use. Tob Control (2000) 1.62
HIV infection among lower socioeconomic strata prostitutes in Nairobi. AIDS (1990) 1.62
Integrin alpha 2 beta 1 is a positive regulator of collagenase (MMP-1) and collagen alpha 1(I) gene expression. J Biol Chem (1995) 1.56
Stage-and tissue-specific expression of a Col2a1-Cre fusion gene in transgenic mice. Matrix Biol (2001) 1.55
Factor VIII related antigen in connective tissue disease patients and relatives. Br J Rheumatol (1990) 1.55
Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand (1996) 1.55
Incidence and prevalence of chlamydia, herpes, and viral hepatitis in a homeless adolescent population. Sex Transm Dis (2001) 1.54
International applicability of the VF-14. An index of visual function in patients with cataracts. Ophthalmology (1997) 1.51
Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J Cell Sci (2000) 1.50
Marfan Database (third edition): new mutations and new routines for the software. Nucleic Acids Res (1998) 1.49
Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J Biol Chem (1998) 1.49
Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn (1997) 1.44
p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression. Mol Cell Biol (2001) 1.43
A potent far-upstream enhancer in the mouse pro alpha 2(I) collagen gene regulates expression of reporter genes in transgenic mice. J Cell Biol (1996) 1.42
Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts. Arthritis Rheum (2002) 1.40
Patients' acceptance of waiting for cataract surgery: what makes a wait too long? Soc Sci Med (1997) 1.39
Magnetic resonance imaging of osteitis condensans ilii. Br J Rheumatol (1994) 1.39
Malabsorption caused by coeliac disease in patients who have scleroderma. Br J Rheumatol (1995) 1.38
Visual outcomes of cataract surgery in the United States, Canada, Denmark, and Spain. Report From the International Cataract Surgery Outcomes Study. Arch Ophthalmol (1998) 1.38
Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene. Proc Natl Acad Sci U S A (1991) 1.37
Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J Biol Chem (1999) 1.37
Construction and partial characterization of two recombinant cDNA clones for procollagen from chicken cartilage. Nucleic Acids Res (1982) 1.35
Coordinated regulation of type I and type III collagen production and mRNA levels of pro alpha 1(I) and pro alpha 2(I) collagen in cultured morphea fibroblasts. Arch Dermatol Res (1987) 1.35
Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem (1996) 1.35
Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol (1997) 1.34
Serology of Lyme disease. Lancet (1986) 1.32
Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann Rheum Dis (2004) 1.30
Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J Biol Chem (1999) 1.30
The mouse collagen X gene: complete nucleotide sequence, exon structure and expression pattern. Biochem J (1993) 1.28
Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br J Rheumatol (1996) 1.27
Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol (1997) 1.26
Normal long bone growth and development in type X collagen-null mice. Nat Genet (1994) 1.26
Interleukin-1 increases collagen production and mRNA levels in cultured skin fibroblasts. Biochim Biophys Acta (1987) 1.25
Enhanced expression of TGF-beta and c-fos mRNAs in the growth plates of developing human long bones. Development (1988) 1.25
Continuity of pediatric ambulatory care in a universally insured population. Pediatrics (1996) 1.25
Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization. J Invest Dermatol (1988) 1.21
A metaphyseal defect model of the femur for studies of murine bone healing. Bone (2001) 1.19
Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development. FEBS Lett (1996) 1.18
New opportunities for Chlamydia prevention: applications of science to public health practice. Sex Transm Dis (1995) 1.16
Validity and reliability of three methods used in the diagnosis of Raynaud's phenomenon. The UK Scleroderma Study Group. Br J Rheumatol (1993) 1.16
Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro alpha 1(II) collagen chain. J Cell Biol (1992) 1.16
Localization of the expression of types I, III, and IV collagen, TGF-beta 1 and c-fos genes in developing human calvarial bones. Dev Biol (1988) 1.15
Managing health services: how the Population Health Information System (POPULIS) works for policymakers. Med Care (1999) 1.12
Collagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor alpha and transforming growth factor beta. Cell Growth Differ (1997) 1.12
Characterization of trimethoprim resistance by use of probes specific for transposon Tn7. Antimicrob Agents Chemother (1984) 1.10
Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol (1999) 1.10
Willingness to pay to shorten waiting time for cataract surgery. Health Aff (Millwood) (1997) 1.10
Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon. Arthritis Rheum (1994) 1.10
Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc Natl Acad Sci U S A (1996) 1.10
PrP gene dosage and long term potentiation. Neurodegeneration (1995) 1.09
Evaluation of transforming growth factor beta and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization. J Invest Dermatol (1990) 1.09
Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder. Int J Cancer (2000) 1.08
Construction of a human pro alpha 1(III) collagen cDNA clone and localization of type III collagen expression in human fetal tissues. Matrix (1989) 1.08
Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects. Am Rev Respir Dis (1992) 1.08
Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation. Health Technol Assess (2012) 1.07
How many general surgeons do you need in rural areas? Three approaches to physician resource planning in southern Manitoba. CMAJ (1996) 1.07
Minority women and tobacco: implications for smoking cessation interventions. Ann Behav Med (1997) 1.07
Developmental expression of a type II collagen/beta-galactosidase fusion gene in transgenic mice. Dev Dyn (1995) 1.06
Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls. Ann Rheum Dis (2001) 1.06
Role of cathepsin K in normal joints and in the development of arthritis. Curr Drug Targets (2007) 1.06
A role for decorin in the structural organization of periodontal ligament. Lab Invest (2000) 1.06
Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors. Oncogene (1997) 1.06
Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K. J Bone Miner Res (2001) 1.05
Cross-cultural differences in the reporting of global functional capacity: an example in cataract patients. Med Care (1998) 1.05
Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset: a controlled study. Ann Rheum Dis (1988) 1.05
Comparative effects of interleukin-1 and tumor necrosis factor-alpha on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. J Invest Dermatol (1991) 1.05
Human pro alpha 1(I) collagen: cDNA sequence for the C-propeptide domain. Nucleic Acids Res (1988) 1.04
Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer. Rheumatology (Oxford) (2008) 1.04
Localization of type I and III collagen and fibronectin production in injured gastrocnemius muscle. Lab Invest (1991) 1.04
Expression of Sox9 and type IIA procollagen during attempted repair of articular cartilage damage in a transgenic mouse model of osteoarthritis. Arthritis Rheum (2001) 1.03
Assembly of cartilage collagen fibrils is disrupted by overexpression of normal type II collagen in transgenic mice. Proc Natl Acad Sci U S A (1993) 1.02
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis (2001) 1.02
Histomorphometric and molecular biologic comparison of bioactive glass granules and autogenous bone grafts in augmentation of bone defect healing. J Biomed Mater Res (1997) 1.01
Increased type I collagen mRNA levels in cultured scleroderma fibroblasts. Biochim Biophys Acta (1984) 1.01